SEC Form 4 · accession 0001104659-17-038149
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darlene M Deptula-Hicks
Officer — SVP & Chief Financial Officer
Period of report
Jun 6, 2017
Accepted (ET)
Jun 8, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2017 | P | 4,000 | $3.58 | A | 4,000 | D |
Table II — derivative securities
No Table II lines on this filing.